POINT Biopharma Global Inc. (PNT) Misses Q2 EPS by 5c

POINT Biopharma Global Inc. (NASDAQ: PNT) reported Q2 EPS of ($0.27), $0.05 worse than the analyst estimate of ($0.22).

For earnings history and earnings-related data on POINT Biopharma Global Inc. (PNT) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c